Abrdn PLC Uni Qure N.V. Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Abrdn PLC holds 1,509,335 shares of QURE stock, worth $23 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,509,335
Previous 1,929,061
21.76%
Holding current value
$23 Million
Previous $9.51 Million
180.27%
% of portfolio
0.05%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding QURE
# of Institutions
154Shares Held
40.4MCall Options Held
925KPut Options Held
617K-
Vestal Point Capital, LP New York, NY4.75MShares$72.4 Million1.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.78MShares$42.4 Million0.81% of portfolio
-
Boxer Capital, LLC San Diego, CA2.23MShares$33.9 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$33.4 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$29.3 Million0.0% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $712M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...